filgrastim [clinicaltrials_resource:c2c2c86fcd33667a221b4d853487df1a]
Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria [clinicaltrials:NCT00004464]Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes [clinicaltrials:NCT00004787]Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia [clinicaltrials:NCT00005896]Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's Anemia [clinicaltrials:NCT00005898]Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00005986]Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00005987]Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer [clinicaltrials:NCT00005993]Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease [clinicaltrials:NCT00005998]Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases [clinicaltrials:NCT00006055]Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders [clinicaltrials:NCT00006056]Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease [clinicaltrials:NCT00010387]Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome [clinicaltrials:NCT00010400]Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus [clinicaltrials:NCT00010413]Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis [clinicaltrials:NCT00014755]Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma [clinicaltrials:NCT00017160]Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis [clinicaltrials:NCT00017628]Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus [clinicaltrials:NCT00017641]BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy [clinicaltrials:NCT00020371]A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00117455]Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation [clinicaltrials:NCT00207792]Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer [clinicaltrials:NCT00237575]Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00290628]
intervention [clinicaltrials_vocabulary:intervention]
filgrastim [clinicaltrials_resource:c2c2c86fcd33667a221b4d853487df1a]
Bio2RDF identifier
c2c2c86fcd33667a221b4d853487df1a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c2c2c86fcd33667a221b4d853487df1a
intervention name [clinicaltrials_vocabulary:intervention-name]
filgrastim
identifier
clinicaltrials_resource:c2c2c86fcd33667a221b4d853487df1a
title
filgrastim
@en
type
label
filgrastim [clinicaltrials_resource:c2c2c86fcd33667a221b4d853487df1a]
@en